Mumbai — ADVENT, a global leader in analytical chemistry and impurity management solutions, is addressing one of the pharmaceutical industry's most pressing challenges: Nitrosamine Drug Substance-Related Impurities (NDSRIs). With the growing concern surrounding the safety and regulatory compliance of drug products, ADVENT has taken pioneering steps to develop high-purity NDSRI reference standards and analytical solutions that help pharmaceutical manufacturers navigate the complexities of nitrosamine impurity management.
NDSRIs are structurally similar to active pharmaceutical ingredients (APIs) and are generated when nitrosating agents react with functional groups in APIs or their intermediates. These impurities are often unique to each drug substance, making them difficult to predict, identify, and control. As a result, the presence of NDSRIs presents a significant challenge for manufacturers striving to meet rigorous safety standards set by regulatory agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
"The emergence of NDSRIs as a key concern in drug manufacturing is a reminder of the critical need for innovation in impurity management," said Dr. Rashmi Ranjan Mohanty, Director - Technical, Advent. "Our role in providing high-purity reference standards and state-of-the-art analytical solutions positions ADVENT as a vital partner for pharmaceutical companies working to address the risks associated with these impurities. Our commitment to advancing analytical methods and ensuring regulatory compliance supports drug manufacturers in safeguarding patient safety."
ADVENT’s Commitment to NDSRI Management
ADVENT has been at the forefront of developing a comprehensive portfolio of NDSRI reference standards, which are essential for accurately quantifying and validating methods for NDSRI detection. These custom-synthesized reference materials empower pharmaceutical companies to meet the evolving regulatory requirements for nitrosamine impurities and streamline the process of drug development.
The company’s innovative approach ensures that manufacturers are equipped with the tools necessary to detect NDSRIs with precision and reduce the risks associated with their presence in pharmaceutical products. ADVENT’s reference materials are available in a wide range of purities, and customized packs are offered to meet the diverse needs of pharmaceutical manufacturers worldwide.
Regulatory Challenges and Mitigation Strategies
In addition to offering NDSRI reference standards, ADVENT provides valuable insights into the regulatory landscape surrounding these impurities. With limited toxicological data available for many NDSRIs, establishing scientifically sound acceptable intake (AI) limits has become a challenge for regulatory agencies. ADVENT works closely with manufacturers to develop robust control and mitigation strategies that include process optimization, raw material quality control, and environmental safeguards. These strategies are critical in preventing the formation of NDSRIs during drug manufacturing.
Looking Ahead: ADVENT’s Role in Shaping the Future of Impurity Management
As the pharmaceutical industry continues to grapple with the complexities of nitrosamine impurity management, ADVENT remains committed to advancing the science of impurity detection and offering comprehensive solutions to manufacturers. The company’s growing portfolio of NDSRI standards is set to become even more essential as the pharmaceutical industry evolves and faces increasing scrutiny from regulatory bodies.
"The future of drug safety and compliance hinges on continuous innovation and collaboration," said Dr. Rashmi Ranjan Mohanty, Director - Technical, Advent. "At ADVENT, we are dedicated to leading the charge in providing the highest quality standards and analytical support, ensuring that pharmaceutical manufacturers can deliver safe and effective products to patients around the world."
About ADVENT
ADVENT is a global leader in providing analytical chemistry services and impurity management solutions to the pharmaceutical, biotechnology, and chemical industries. With over [X] years of experience, ADVENT has built a reputation for delivering high-quality reference standards, advanced analytical services, and customized solutions that help clients navigate regulatory challenges and ensure product safety.
For more information, visit www.adventchembio.com or drop an email at sales@adventchembio.com.